MintLean R·
Eli Lilly-backed Scribe Therapeutics climbs 67% after raising $128.7 million in an upsized IPO
Scribe Therapeutics, a developer of gene therapies for heart diseases, rose 67% after raising $128.7 million in its IPO.
Read at Mint →
Markets · 1 sources covering this
Eli Lilly-backed Scribe Therapeutics climbs 67% after raising $128.7 million in an upsized IPO
Scribe Therapeutics, a developer of gene therapies for heart diseases, rose 67% after raising $128.7 million in its IPO.
Coverage spectrum
0 L · 0 C · 1 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/77cdb026761cab279fa37e1ccaf0851c55bc04d8" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Eli Lilly-backed Scribe Therapeutics climbs 67% after raising $128.7 million in an upsized IPO"></iframe>
